Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report report published on Monday morning. The brokerage issued a hold rating on the stock.

Milestone Scientific Trading Down 5.8 %

Shares of Milestone Scientific stock opened at $0.93 on Monday. Milestone Scientific has a 12-month low of $0.54 and a 12-month high of $1.39. The company has a market cap of $72.64 million, a P/E ratio of -13.32 and a beta of 1.41. The company’s fifty day simple moving average is $1.10 and its two-hundred day simple moving average is $0.96.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Carnegie Investment Counsel boosted its position in shares of Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. Geode Capital Management LLC lifted its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific during the 3rd quarter valued at $48,000. Renaissance Technologies LLC grew its position in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after buying an additional 53,198 shares during the period. Finally, World Investment Advisors LLC bought a new position in shares of Milestone Scientific in the 3rd quarter worth about $91,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.